Cells Seen; How to Tell, What to Tell; New UC Campus Hiring Scientists

TRAINING @ | Cells Seen WHAT: Immunocytochemistry, in situ hybridization & live cell imaging WHERE: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY WHY: Course teaches and emphasizes the use of specialized techniques in microscopy, in situ hybridization, and immunocytochemistry ADVANTAGES: Several protocols are presented for students to assess their merits in relation to their own research WHEN: October 18-31, 2003 DEADLINE: July 15, 2003 COST: $2385 (US) CONTACT: An

Written byMark Cohen
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

TRAINING @ | Cells Seen

WHAT: Immunocytochemistry, in situ hybridization & live cell imaging

WHERE: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

WHY: Course teaches and emphasizes the use of specialized techniques in microscopy, in situ hybridization, and immunocytochemistry

ADVANTAGES: Several protocols are presented for students to assess their merits in relation to their own research

WHEN: October 18-31, 2003

DEADLINE: July 15, 2003

COST: $2385 (US)

CONTACT: Andrea Stephenson, 516-367-8344, stephens@cshl.edu

URL: meetings.cshl.org/2003/2003c-situ.htm

TIP TROVE | How to Tell, What to Tell

Before discussing your research with any company, at the very least, you should arrange a confidentiality disclosure agreement. The best-case scenario is to have already filed for a patent application. Scientists frequently make the mistake of believing they're meeting with company executives just to talk about science. Often times, companies want to hear what's going on, even if they don't think there's a real deal in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies